Skin Cancer | Tumor

Frontline Libtayo Could Help Patients with Advanced Cutaneous Squamous Cell Carcinoma Avoid Surgery

August 24th 2020, 3:00pm


Dr. Jennifer L. Atlas notes that while these results could lead to a paradigm shift, surgery and radiation aren’t being eliminated as treatment options.

Personalized Vaccine Shows Long-Term Survival Benefits for Patients with High-Risk Skin Cancer

August 19th 2020, 6:00pm


“With data showing a two-fold increase in disease-free survival with the vaccine alone and in combination with checkpoint inhibitors, we hope to one day change the narrative for people with melanoma — turning this disease into a chronic condition that can be treated and managed over time,” said Dr. Mark B. Faries.

Friday Frontline: Beirut Explosion Costs Children’s Access to Cancer Treatment, Researchers Find Intestinal Bacteria ‘Supercharges’ Immunotherapy and More

August 14th 2020, 2:00pm


From the recent Beirut explosion compromising pediatric oncology hospitals, to researchers looking at how intestinal bacteria can supercharge targeted immunotherapies, here’s what’s happening in the cancer landscape this week.

FDA Approves Tecentriq in Combination with Cotellic and Zelboraf for Patients with Advanced Skin Cancer

July 31st 2020, 1:20am


The Food and Drug Administration has approved Tecentriq in combination with Cotellic and Zelboraf for the treatment of patients with BRAF V600 mutation-positive advanced melanoma.

The Future of Melanoma Treatment May Be Complex, But 'Where There's a Will, There's a Way'

July 28th 2020, 1:07am


Research in the melanoma space is finding itself facing complex challenges in implementing CAR-T cell therapy, but according to one expert these challenges are not insurmountable.

Investigating a Health Gap in Skin Cancer

July 23rd 2020, 1:00am


CURE Community Vlog: One Patient's Journey With Merkel Cell Carcinoma

July 11th 2020, 10:00pm


“You have to speak up. What you don’t say is the most predictive of the care you don’t get.”

Speaking Out: Taking Action Against Skin Cancer

July 4th 2020, 6:00pm


Patients can pick from a growing array of treatments, from same-day- results surgery to game-changing immunotherapy, to fight the most common type of cancer.

FDA Approves Keytruda for Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma

June 24th 2020, 11:57pm


The Food and Drug Administration approved Keytruda to treat patients with recurrent or metastatic cutaneous squamous cell carcinoma that cannot be treated with surgery or radiation.

Tafinlar and Mekinist Improve Long-Term Survival in Patients with BRAF Positive Melanoma

June 19th 2020, 5:00pm


“The relapse-free survival curves for both treatment arms appear to be reaching a plateau, which is a good sign if we are talking about cure,” said lead study author Dr. Axel Hauschild.